Research
Abey Research Group
The   synthesis   of   new   ribosomes   is   critical   for   the   survival   of   all   organisms.   In the   early   1960s,   Nomura   and   colleagues   found   30S   ribosomal   subunits   can   be assembled   in   vitro,   and   the   assembly   is   highly   cooperative   and   hierarchical. Since   then,   thermodynamics   and   kinetics   of   protein   addition,   RNA   folding during   ribosomal   assembly,   and   the   structural   basis   for   cooperative   protein addition   have   been   studied   extensively.   In   addition   to   r-proteins,   various   other assembly   factors   and   nucleotide   modification   enzymes   are   involved   in   the ribosomal   assembly.   Interestingly,   in   vivo,   both   ribosomal   assembly   and   rRNA modifications   occur   co-transcriptionally.   However,   less   is   known   about   these nucleotide   modification   steps   and   how   these   steps   are   integrated   into   the mechanism   of   ribosomal   protein   addition.   Nucleotide   modification   steps   of rRNA   can   influence   the   ribosomal   assembly   in   two   separate   ways.      First,   post- transcriptional   modifications   can   perturb   local   RNA   structure,   stability,   and dynamics    hence    modulating    RNA    folding.    Similarly,    modified    nucleotides provide    additional    hydrophobic    patches    that    will    change    the    affinity    of ribosomal      proteins.      Secondly,      thermodynamic      cooperativity      between modification    enzymes    and    r-proteins    generates    low-energy    pathways    for assembly   to   proceed.   Conversely,   kinetic   cooperativity   between   modification enzymes    and    r-proteins    can    prevent    the    formation    of    undesirable    and unproductive      assembly      intermediates.      In      our      lab,      we      investigate thermodynamic   and   kinetic   cooperativity   of   binding   between   rRNA   modification enzyme and r-proteins. read more...
Investigation of the ability of rRNA modification enzymes to influence 30S ribosome assembly
Nucleotide      modifications      such      as      N6-methyladenosines      (m 6 A),      5- methylcytosines,   and   pseudouridines   are   observed   throughout   the   eukaryotic transcriptome.   The   levels   of   nucleotide   modifications   vary   under   various   stress conditions,    including    heat    shock,    starvation,    and    oxidative    stress.    These observed   changes   in   mRNA   modification   levels   have   shown   to   control   viral infections,   sperm   maturation,   and   cancer   progression.   In   cells,   m 6 A   levels   are controlled   by   methyl   writers   and   erasers.   Methyl   reader   proteins   recognize methylations   and   facilitate   mRNA   editing,   processing,   degradation,   or   increase translation.    In    the    Abey    lab,    we    study    how    methyl    readers    recognize methylated mRNA using various biochemical and biophysical techniques. read more...
Study of N6-methyladenosine recognition by methyl readers
Since   the   discovery   of   penicillin,   many   antibiotic-resistant   bacterial   strains have    emerged    all    throughout    the    world.    According    to    the    World    Health Organization   (WHO),   antibiotic   resistance   of   bacteria   has   become   a   global health   crisis.   Multidrug-resistant   Mycobacterium   tuberculosis   has   led   to   TB infections, which alone have caused more than 250,000 deaths in 2015. Ribosomes   are   the   target   for   many   classes   of   antibiotics.   These   diverse   classes of    antibiotics    target    the    initiation,    elongation,    and    termination    steps    of translation    in    bacteria.    The    correlation    between    nucleotide    modification enzymes,   ribosome   assembly,   and   antibiotic   resistance   is   well   known.   For example,    the    absence    of    methyltransferase    enzyme    KsgA,    cause    both ribosome   assembly   defects   and   resistance   towards   kasugamycin.   In   the   Abey lab,   we   investigate   the   potential   of   nucleotide   modification   machinery   as   a potential drug target. read more...
Discovery of small-molecular inhibitors of modification enzymes
Abey research group